Literature DB >> 33065179

Continuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology.

Rodolfo J Galindo1, Grazia Aleppo2.   

Abstract

Monitoring of glucose levels is essential to effective diabetes management. Over the past 100 years, there have been numerous innovations in glucose monitoring methods. The most recent advances have centered on continuous glucose monitoring (CGM) technologies. Numerous studies have demonstrated that use of continuous glucose monitoring confers significant glycemic benefits on individuals with type 1 diabetes (T1DM) and type 2 diabetes (T2DM). Ongoing improvements in accuracy and convenience of CGM devices have prompted increasing adoption of this technology. The development of standardized metrics for assessing CGM data has greatly improved and streamlined analysis and interpretation, enabling clinicians and patients to make more informed therapy modifications. However, many clinicians many be unfamiliar with current CGM and how use of these devices may help individuals with T1DM and T2DM achieve their glycemic targets. The purpose of this review is to present an overview of current CGM systems and provide guidance to clinicians for initiating and utilizing CGM in their practice settings.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AGP; Ambulatory Glucose Profile; CGM; Continuous glucose monitoring; HbA1c; Intermittently scanned CGM; Real-time CGM; Type 1 diabetes; Type 2 diabetes; isCGM; rtCGM

Year:  2020        PMID: 33065179      PMCID: PMC7736459          DOI: 10.1016/j.diabres.2020.108502

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  14 in total

1.  Virtual visits and the use of continuous glucose monitoring for diabetes care in the era of COVID-19.

Authors:  Patricia Underwood; Jennifer Hibben; Jolynn Gibson; Monica DiNardo
Journal:  J Am Assoc Nurse Pract       Date:  2021-12-14       Impact factor: 1.165

2.  Hospital Diabetes Meeting 2022.

Authors:  Jingtong Huang; Andrea M Yeung; Kevin T Nguyen; Nicole Y Xu; Jean-Charles Preiser; Robert J Rushakoff; Jane Jeffrie Seley; Guillermo E Umpierrez; Amisha Wallia; Andjela T Drincic; Roma Gianchandani; M Cecilia Lansang; Umesh Masharani; Nestoras Mathioudakis; Francisco J Pasquel; Signe Schmidt; Viral N Shah; Elias K Spanakis; Andreas Stuhr; Gerlies M Treiber; David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2022-07-29

3.  Hypoglycemic and Hyperglycemic Crises Among U.S. Adults With Diabetes and End-stage Kidney Disease: Population-Based Study, 2013-2017.

Authors:  Rodolfo J Galindo; Mohammed K Ali; Shealeigh A Funni; Andrew B Dodge; Shaheen S Kurani; Nilay D Shah; Guillermo E Umpierrez; Rozalina G McCoy
Journal:  Diabetes Care       Date:  2022-01-01       Impact factor: 17.152

4.  Clinical Application of Time in Range and Other Metrics.

Authors:  Grazia Aleppo
Journal:  Diabetes Spectr       Date:  2021-05-25

Review 5.  Type 1 diabetes mellitus: much progress, many opportunities.

Authors:  Alvin C Powers
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

Review 6.  Advances, Challenges, and Cost Associated with Continuous Glucose Monitor Use in Adolescents and Young Adults with Type 1 Diabetes.

Authors:  Karishma A Datye; Daniel R Tilden; Angelee M Parmar; Eveline R Goethals; Sarah S Jaser
Journal:  Curr Diab Rep       Date:  2021-05-15       Impact factor: 4.810

Review 7.  Dual-hormone artificial pancreas for management of type 1 diabetes: Recent progress and future directions.

Authors:  Marco Infante; David A Baidal; Michael R Rickels; Andrea Fabbri; Jay S Skyler; Rodolfo Alejandro; Camillo Ricordi
Journal:  Artif Organs       Date:  2021-07-15       Impact factor: 2.663

Review 8.  Current treatment options and challenges in patients with Type 1 diabetes: Pharmacological, technical advances and future perspectives.

Authors:  Federico Boscari; Angelo Avogaro
Journal:  Rev Endocr Metab Disord       Date:  2021-03-23       Impact factor: 6.514

Review 9.  Products for Monitoring Glucose Levels in the Human Body With Noninvasive Optical, Noninvasive Fluid Sampling, or Minimally Invasive Technologies.

Authors:  Trisha Shang; Jennifer Y Zhang; Andreas Thomas; Mark A Arnold; Beatrice N Vetter; Lutz Heinemann; David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2021-06-13

10.  Use of a Continuous Glucose Monitoring System in High-Risk Hospitalized Noncritically Ill Patients With Diabetes After Cardiac Surgery and During Their Transition of Care From the Intensive Care Unit During COVID-19: A Pilot Study.

Authors:  Ann T Sweeney; Samara Pena; Jeena Sandeep; Bryan Hernandez; Ye Chen; Janis L Breeze; Aysegul Bulut; Karen Feghali; Moaz Abdelrehim; Mohamed Abdelazeem; Padmavathi Srivoleti; Linda Salvucci; Susan Berry Cann; Catalina Norman
Journal:  Endocr Pract       Date:  2022-03-08       Impact factor: 3.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.